5-(dimethylamino)-n-(3,4-dimethyl-5-isoxazolyl)-1-naphthalenesulfonamide has been researched along with daidzein in 1 studies
Studies (5-(dimethylamino)-n-(3,4-dimethyl-5-isoxazolyl)-1-naphthalenesulfonamide) | Trials (5-(dimethylamino)-n-(3,4-dimethyl-5-isoxazolyl)-1-naphthalenesulfonamide) | Recent Studies (post-2010) (5-(dimethylamino)-n-(3,4-dimethyl-5-isoxazolyl)-1-naphthalenesulfonamide) | Studies (daidzein) | Trials (daidzein) | Recent Studies (post-2010) (daidzein) |
---|---|---|---|---|---|
73 | 0 | 8 | 1,885 | 136 | 753 |
Protein | Taxonomy | 5-(dimethylamino)-n-(3,4-dimethyl-5-isoxazolyl)-1-naphthalenesulfonamide (IC50) | daidzein (IC50) |
---|---|---|---|
rac GTPase-activating protein 1 isoform a | Homo sapiens (human) | 91.26 | |
Estrogen receptor | Homo sapiens (human) | 2.97 | |
Aldehyde dehydrogenase, mitochondrial | Homo sapiens (human) | 9 | |
UDP-glucuronosyltransferase 1A1 | Homo sapiens (human) | 7.3 | |
Transporter | Rattus norvegicus (Norway rat) | 0.45 | |
Estrogen receptor beta | Homo sapiens (human) | 1.6568 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Budhiraja, RD; Garg, A; Katyal, T | 1 |
1 other study(ies) available for 5-(dimethylamino)-n-(3,4-dimethyl-5-isoxazolyl)-1-naphthalenesulfonamide and daidzein
Article | Year |
---|---|
Combination of daidzein, hemin and bms182874 halts the progression of diabetes-induced experimental nephropathy.
Topics: Animals; Cytoprotection; Dansyl Compounds; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Disease Progression; Drug Combinations; Drug Evaluation, Preclinical; Hemin; Isoflavones; Kidney; Male; Rats; Rats, Wistar; Streptozocin | 2013 |